Skip to content

Clinical trials

Completed Graft vs Host Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Status: Completed Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20061
20072
20081
20175
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group2
Incyte Corporation2
Mallinckrodt2
Mesoblast, Inc.2
Pharmacyclics LLC.2
Cynata Therapeutics Limited1
Novartis Pharmaceuticals1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease13
Bronchiolitis Obliterans Syndrome3
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia, Refractory1
Anemia, Refractory, with Excess of Blasts1
Burkitt Lymphoma1
Congenital Abnormalities1
Hodgkin Disease1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.